Transform your decision making with comprehensive market landscape insight
Effective decision-making can make or break your success. CDMO Intelligence is your secret weapon in that decision making process. Access CDMO screening, molecular landscape insights, detailed manufacturing capabilities, and accurate volume forecasts. You’ll have a wealth of data and industry insights at your fingertips, backed by gold standard financial forecast methodologies. With our trusted CDMO Intelligence platform, you’ll identify potential risks and mitigate them effectively to maximise your success.
CDMO Intelligence: Empowering your decision-making process.
CDMO Intelligence provides you with the resources you need to identify potential risks, uncover key opportunities, and to make the best decisions for your business. Our solution empowers you to:
- Develop effective strategies. Backed by trusted data and comprehensive insights, our solution ensures that your strategy is validated and based on reliable information.
- Assess future market potential: Uncover untapped opportunities and gain insight into the potential of the market.
- Stay ahead of competitors: With CDMO Intelligence, you’ll have access to competitive intelligence, enabling you to stay ahead of the competition.
- Streamline decision-making: Save time by streamlining your decision-making process. Spend less time searching for information and more time making impactful decisions.
How we help
CDMO Screener
Gain insights into the market size by technology type/subtype. Identify leading CDMOs in each technology area and assess consensus forecasts for drugs manufactured by CDMOs.
Molecular Landscape
Obtain competitive intelligence insights. Identify specific CDMOs based on service offering, location, and molecule focus. Analyse CDMO facilities and service offerings to assess strengths and weaknesses. Explore the drugs manufactured by a CDMO and their production sites.
Business Development Insights
Understand which CDMO a pharma company currently uses for drug manufacturing. Identify early-stage pipeline drugs for business development purposes. Identify white spaces and potential partners. PTRS and peak sales for CDMO-developed drugs.
Download CDMO Brochures
CDMO
Put the power of machine learning to work. Analyse millions of data points across the full clinical pipeline to discern critical connections between risk and return.
Consulting
Identify commercial opportunities, confidently target clinical needs, and accurately gauge an asset’s worth.
Finance
Understand the pharmaceutical market’s past, present, and future performance with over two decades of commercial data and a continually extending window of consensus forecasts.
Pharma
Understand the pharmaceutical market’s past, present, and future performance with over two decades of commercial data and a continually extending window of consensus forecasts.
How Evaluate Supports Your Success
With CDMO Intelligence, you’ll identify potential risks and make well-informed decisions to maximize your success.
Our tool empowers you to:
1
CDMO Screener
Gain insights into the market size by technology type or subtype. Identify leading CDMOs in each technology area and assess consensus forecasts for drugs manufactured by CDMOs.
2
Molecular Landscape
Obtain competitive intelligence insights. Identify specific CDMOs based on service offering, location, and molecule focus. Analyse CDMO facilities and service offerings to assess strengths and weaknesses. Explore the drugs manufactured by a CDMO and their production sites.
3
Enhanced Due Diligence
Gain an objective view of the CDMO landscape and market size. Understand market dynamics and the ROI potential for CDMO investments. Assess CDMO portfolios and associated product commercial potential. Evaluate CDMO capacity and future demand for informed investment decisions.
4
Volume Forecasting
Understand the demand for manufacturing specific drugs by kilogram. Identify drugs with growing demand. A profile key account is needed for manufacturing. Inform pricing strategy and investment in new capabilities or facilities.
5
Contact Finder
Easily connect with senior-level decision-makers within potential partner organisations. Build crucial partnerships and collaborations.
Evaluate makes it possible for us to assess the commercial value for different products, as well as understand the major trends in the pharmaceutical industry.
DR. HIROHISA NAKADA, ASSOCIATE DIRECTOR, BUSINESS DEVELOPMENT, OTSUKA HOLDINGS
Ready to learn more? Contact us today to get started.
Related Resources
Understand the context. Data-driven news and analysis for the pharma, biotech and medtech sectors.
Kelly Chamberlain may not have been at the company very long, but that didn’t stop me swooping in to find out a little more about her. Kelly has joined Norstella,...
If you missed our recent webinar, AI and ML in Pharma: Redefining the Forecasting Landscape, then I hope it’s because you were on a lovely vacation somewhere. Now that you’re...
There is no shortage of discussion about the opportunities presented by artificial intelligence and AI in the pharma industry. 50% of global healthcare companies plan to implement AI strategies by...
Evaluate’s annual World Preview report is a must-read for many in the pharma industry. Each year, we pull together some of our key pharma forecasts to build a picture of...
Can Forecasting Help Identify Market Opportunities for Pharmaceutical Companies? Forecasting serves to help pharmaceutical companies identify market opportunities, particularly when taking a sales-based approach and considering the wider competitive set....
Many pharmaceutical companies are harnessing digital solutions to elevate global forecasting. Digital tools, such as cloud-based, SaaS environments, are powering efficient, streamlined, and intelligent forecasting processes. But, for technological solutions...